Talentförderung und -bindung Projektmanagement: Leitung und Mitarbeit an HR-Projekten, sowohl innerhalb des Manufacturing Bereichs... als auch gruppenübergreifend in der Camlog Gruppe Erfahrung im modernen Manufacturing HR Umfeld (Medtech, Pharma, Chemie, Automotive...
Take the lead of our global MES team and drive the development of our Manufacturing Execution System (MES)! As a leader... Stakeholder management with our strategic external partner Active co-design of the Manufacturing Execution System FrontEnd...
Akkodis ist ein Vorreiter in der Smart Industry und ein weltweit führendes Unternehmen in den Bereichen Engineering, IT, Forschung und Entwicklung. Als globaler Partner in einer sich ständig verändernden Technologie- & Wettbewerbsumgebung u...
GO! Manufacturing Program - Prozessingenieur Papierverarbeitung (d/w/m) Für Essity spielen ausgebildete Ingenieure... und Neues auszuprobieren. Das Traineeprogramm "GO! Manufacturing Program" besteht aus 4 Modulen und fokussiert...
Chile, home to the world’s biggest lithium reserves, is confident that investors will compete for licenses to drill new deposits even amid a worsening global glut that’s squeezing the battery-metal industry. Continue Reading »
Gold Prices Today: Gold of 99.9 and 99.5 per cent purity grew ₹2,320 each in the last seven trading sessions. However, silver prices declined ₹500 to ₹93,500 per kg from the previous close Continue Reading »
At 11:57 a.m. ET, the Dow Jones Industrial Average rose 0.58 per cent, the S&P 500 gained 0.14 per cent, the Nasdaq Composite lost 0.19 per cent Continue Reading »
Expert view: Mohit Khanna anticipates the Union Budget 2025 will prioritize youth, women, the poor, and farmers, with increased spending on rural housing, irrigation, and employment-linked incentives. Continue Reading »
HPCL Q3 Results: The state-owned OMC's revenue from operations in the third quarter of current fiscal rose to ₹1.10 lakh crore led by better marketing margins. Continue Reading »
Dr Reddy's Laboratories reported a 2% YoY increase in PAT to ₹1,413.3 crore for Q3 2024, driven by a 16% rise in revenue to ₹8,358.6 crore. The company invested ₹6.7 billion in R&D, focusing on complex generics and biosimilars. Continue Reading »